Global Health Limited — Important, 04-02-2025: Financial Result Updates

Revenue from operations for Global Health Limited reached ₹9,434.36 crore in the third quarter, marking a year-over-year growth of 12.7% from ₹8,364.54 crore. This growth is primarily attributable to increased demand for healthcare services and strategic market expansions.

Net profit for the quarter stood at ₹1,428.58 crore compared to ₹1,235.41 crore in the same period last year, reflecting an 15.6% increase. Earnings Per Share (EPS) improved to ₹5.32 from ₹4.60, indicating strong profitability driven by enhanced service efficacy and potentially lower operational costs.

Total expenses rose to ₹7,703.92 crore, up 12.9% year-over-year, largely influenced by increases in employee benefits and equipment costs, although measures for cost control appear to have mitigated larger impacts. Operating expenses were managed effectively, with a focus on optimizing workforce costs and enhancing operational efficiencies.

The balance sheet remains strong, with reserves of ₹28,519.26 crore, providing a solid foundation for future expansions and operational investments, including a new hospital project in Ranchi with an anticipated capital expenditure of up to ₹50 crore aimed at boosting capacity.

Strategically, Global Health is poised for growth with plans for new facility operationalization and expected synergies from recent expansions. With its improving financial metrics and strategic initiatives, the company presents a favorable landscape for retail investors. A buy is suggested as the outlook appears robust with ongoing healthcare demand dynamics.